Last reviewed · How we verify

NCT06869746: SSTR

Swiss Spinal Tumor Registry (Swiss-STR)

Recruiting now Last updated 19 March 2025
What this trial tests

trial in Spinal Tumors in 250 participants. Currently enrolling.

Timeline
1 January 2023
Primary endpoint
31 December 2027
31 December 2032

Quick facts

Lead sponsorLuzerner Kantonsspital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment250
Start date1 January 2023
Primary completion31 December 2027
Estimated completion31 December 2032
Sites1 location across Switzerland

Conditions studied

Sponsor

Luzerner Kantonsspital — full company profile →

Who can join

18 and older, any sex, with Spinal Tumors or Surgical Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Swiss Spinal Tumor Registry is a prospective REDCap-based registry, collecting data of surgically treated patients with primary and metastatic tumors of the spine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Tumors

Currently open trials in the same condition.

Other Luzerner Kantonsspital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06869746.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing